In vivo studies demonstrated that PSMD14 silencing significantly inhibited tumor formation, whereas PSMD14 overexpression accelerated subcutaneous tumor growth, as shown by weight and tumor volume measurements (Figure S5E, Supporting Information). This evidence concerns the gene PSMD14 and neoplasm.